A detailed history of Cohen Capital Management, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cohen Capital Management, Inc. holds 660 shares of BIO stock, worth $218,717. This represents 0.04% of its overall portfolio holdings.

Number of Shares
660
Holding current value
$218,717
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$263.97 - $344.64 $174,220 - $227,462
660 New
660 $220,000
Q4 2022

Jan 31, 2023

SELL
$351.71 - $456.01 $26,378 - $34,200
-75 Reduced 10.2%
660 $277,000
Q4 2021

Feb 04, 2022

SELL
$708.84 - $794.68 $10,632 - $11,920
-15 Reduced 2.0%
735 $555,000
Q3 2020

Nov 02, 2020

SELL
$454.43 - $535.6 $45,443 - $53,560
-100 Reduced 11.76%
750 $387,000
Q4 2019

Feb 05, 2020

SELL
$319.73 - $374.2 $15,986 - $18,710
-50 Reduced 5.56%
850 $315,000
Q4 2017

Jan 22, 2018

BUY
$216.94 - $271.3 $195,246 - $244,170
900
900 $215,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.16B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cohen Capital Management, Inc. Portfolio

Follow Cohen Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cohen Capital Management, Inc. with notifications on news.